Synapsin III is a key component of α‐synuclein fibrils in Lewy bodies of PD brains |
| |
Authors: | Francesca Longhena Gaia Faustini Tatiana Varanita Michela Zaltieri Vanessa Porrini Isabella Tessari Pietro Luigi Poliani Cristina Missale Barbara Borroni Alessandro Padovani Luigi Bubacco Marina Pizzi PierFranco Spano Arianna Bellucci |
| |
Affiliation: | 1. Department of Molecular and Translational Medicine, University of Brescia, Brescia Italy ; 2. Department of Biology, University of Padova, Padova Italy ; 3. Department of Clinical and Experimental Sciences, University of Brescia, Brescia Italy ; 4. IRCCS San Camillo Hospital for Neurorehabilitation (NHS‐Italy), Venice Lido Italy ; 5. Laboratory of Personalized and Preventive Medicine, University of Brescia, Brescia Italy |
| |
Abstract: | Lewy bodies (LB) and Lewy neurites (LN), which are primarily composed of α‐synuclein (α‐syn), are neuropathological hallmarks of Parkinson''s disease (PD) and dementia with Lewy bodies (DLB). We recently found that the neuronal phosphoprotein synapsin III (syn III) controls dopamine release via cooperation with α‐syn and modulates α‐syn aggregation. Here, we observed that LB and LN, in the substantia nigra of PD patients and hippocampus of one subject with DLB, displayed a marked immunopositivity for syn III. The in situ proximity ligation assay revealed the accumulation of numerous proteinase K‐resistant neuropathological inclusions that contained both α‐syn and syn III in tight association in the brain of affected subjects. Most strikingly, syn III was identified as a component of α‐syn‐positive fibrils in LB‐enriched protein extracts from PD brains. Finally, a positive correlation between syn III and α‐syn levels was detected in the caudate putamen of PD subjects. Collectively, these findings indicate that syn III is a crucial α‐syn interactant and a key component of LB fibrils in the brain of patients affected by PD. |
| |
Keywords: | Lewy bodies, Lewy body dementia, Parkinson''s disease, α ‐ synuclein, synapsin III |
|
|